Joseph E. Blais
Impact in
-
- Pharmaceutical Practices and Patient Outcomes
- Toxicology top 10%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
- Surgery 13
- Lipoproteins and Cardiovascular Health 12
-
- SARS-CoV-2 and COVID-19 Research 3
- COVID-19 Clinical Research Studies 2
- Co-authors
- Ian Chi Kei Wong (30 shared papers)Esther Wai Yin Chan (32 shared papers)Li Wei (5 shared papers)Wallis C. Y. Lau (6 shared papers)Vincent Ka Chun Yan (13 shared papers)Kenneth K. C. Man (4 shared papers)Celine Sze Ling Chui (12 shared papers)Ruth Brauer (2 shared papers)
- Journals
- PLoS ONE (3 papers)Atherosclerosis (2 papers)The American Journal of Gastroenterology (2 papers)CNS Drugs (2 papers)Journal of the American College of Cardiology (2 papers)
- Partner nations
- Hong KongUnited KingdomChina
In The Last Decade
Joseph E. Blais
38 papers receiving 509 citations
Peers
Comparison fields: 5 of 84
- Geriatrics and Gerontology 19
- Toxicology 26
- Family Practice 9
- Pharmacology 27
- Pharmacology 39
Countries citing papers authored by Joseph E. Blais
This map shows the geographic impact of Joseph E. Blais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph E. Blais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph E. Blais more than expected).
Fields of papers citing papers by Joseph E. Blais
This network shows the impact of papers produced by Joseph E. Blais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph E. Blais. The network helps show where Joseph E. Blais may publish in the future.
Co-authors
The 25 scholars most cited alongside Joseph E. Blais, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 117 | |
| 2 | 2021 | 91 | |
| 3 | 2018 | 26 | |
| 4 | 2022 | 24 | |
| 5 | 2023 | 24 | |
| 6 | 2020 | 20 | |
| 7 | 2020 | 17 | |
| 8 | 2022 | 15 | |
| 9 | 2019 | 14 | |
| 10 | 2021 | 13 | |
| 11 | 2022 | 13 | |
| 12 | 2021 | 11 | |
| 13 | 2022 | 11 | |
| 14 | 2011 | 10 | |
| 15 | 2020 | 10 | |
| 16 | 2024 | 10 | |
| 17 | 2022 | 9 | |
| 18 | 2022 | 9 | |
| 19 | 2021 | 7 | |
| 20 | 2022 | 7 |
About Joseph E. Blais
Joseph E. Blais is a scholar working on Surgery, Infectious Diseases, Family Practice, Toxicology and Pharmacology, having authored 44 papers that have together received 517 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (12 papers), Berberine and alkaloids research (3 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers), Medication Adherence and Compliance (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Atrial Fibrillation Management and Outcomes (2 papers), Health Promotion and Cardiovascular Prevention (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Geriatrics and Gerontology (19 citations), Toxicology (26 citations), Family Practice (9 citations), Pharmacology (27 citations) and Pharmacology (39 citations). Joseph E. Blais has collaborated with scholars based in Hong Kong, United Kingdom and China. Frequent co-authors include Ian Chi Kei Wong, Esther Wai Yin Chan, Li Wei, Wallis C. Y. Lau, Vincent Ka Chun Yan, Kenneth K. C. Man, Celine Sze Ling Chui, Ruth Brauer, Yue Wei and Joseph Hayes. Their work appears in journals such as PLoS ONE, Atherosclerosis, The American Journal of Gastroenterology, CNS Drugs and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.